Rare diseases
Investigational molecules
Locations
A study testing SPY072 compared to placebo in adults with moderately to severely active rheumatologic disease
BulgariaA study testing BFB759 compared to placebo to evaluate effectiveness and safety in adult patients with atopic dermatitis
BulgariaA study comparing ziltivekimab to placebo in patients with heart failure with mildly reduced or preserved ejection fraction and inflammation
BulgariaStudy of zasocitinib (TAK-279) and apremilast compared to placebo in adults with moderate to severe plaque psoriasis
BulgariaStudy of Rocatinlimab Treatment for Adults and Adolescents with Moderate to Severe Atopic Dermatitis
BulgariaLong-term safety and effectiveness study of sonelokimab injections for patients with moderate to severe hidradenitis suppurativa
BulgariaStudy of aneratrigine mesilate (iN1011-N17-02) to find the best dose for treating pain in adults with post-herpetic neuralgia
BulgariaComparison of linaprazan glurate versus lansoprazole for healing of erosive esophagitis in adults with gastroesophageal reflux disease
BulgariaEvaluation of Ziltivekimab in Patients with Heart Failure with Mildly Reduced or Preserved Ejection Fraction and Systemic Inflammation
BulgariaLong-Term Safety Study of Plozasiran for Adults with High Triglycerides
BulgariaStudy on the Effectiveness of an MF59-Adjuvanted Influenza Vaccine Compared to a Non-Adjuvanted Vaccine in Adults Aged 65 and Older
BulgariaStudy on the Safety and Effectiveness of IPN10200 for Treating Upper Limb Spasticity in Adults After Stroke or Brain Injury
BulgariaTell us about your condition – we search every trial in Europe and connect you with the right site.
